IRIS Accounts Production v25.1.3.33 15361511 director 19.12.23 31.12.24 31.12.24 false true false false true false Ordinary 1.00000 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh153615112023-12-18153615112024-12-31153615112023-12-192024-12-31153615112023-12-1815361511ns15:EnglandWales2023-12-192024-12-3115361511ns14:PoundSterling2023-12-192024-12-3115361511ns10:Director12023-12-192024-12-3115361511ns10:PrivateLimitedCompanyLtd2023-12-192024-12-3115361511ns10:SmallEntities2023-12-192024-12-3115361511ns10:AuditExempt-NoAccountantsReport2023-12-192024-12-3115361511ns10:SmallCompaniesRegimeForDirectorsReport2023-12-192024-12-3115361511ns10:SmallCompaniesRegimeForAccounts2023-12-192024-12-3115361511ns10:FullAccounts2023-12-192024-12-3115361511ns10:OrdinaryShareClass12023-12-192024-12-31153615111ns10:OrdinaryShareClass12023-12-192024-12-3115361511ns10:RegisteredOffice2023-12-192024-12-3115361511ns5:CurrentFinancialInstruments2024-12-3115361511ns5:ShareCapital2024-12-3115361511ns5:RetainedEarningsAccumulatedLosses2024-12-3115361511ns5:PlantMachinery2023-12-192024-12-3115361511ns5:FurnitureFittings2023-12-192024-12-3115361511ns5:PlantMachinery2024-12-3115361511ns5:FurnitureFittings2024-12-3115361511ns5:DeferredTaxation2023-12-192024-12-3115361511ns5:DeferredTaxation2024-12-3115361511ns10:OrdinaryShareClass12024-12-31
REGISTERED NUMBER: 15361511 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS

FOR THE PERIOD 19 DECEMBER 2023 TO 31 DECEMBER 2024

FOR

JDXTHERAPY LIMITED

JDXTHERAPY LIMITED (REGISTERED NUMBER: 15361511)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE PERIOD 19 DECEMBER 2023 TO 31 DECEMBER 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


JDXTHERAPY LIMITED

COMPANY INFORMATION
FOR THE PERIOD 19 DECEMBER 2023 TO 31 DECEMBER 2024







DIRECTOR: J Dhillon





REGISTERED OFFICE: 131 Watermarque
100 Browning Street
Birmingham
B16 8GZ





REGISTERED NUMBER: 15361511 (England and Wales)





ACCOUNTANTS: Saxon & Co Accountants Ltd
Chartered Certified Accountants
Kings Chambers
Queens Cross
High Street
Dudley
West Midlands
DY1 1QT

JDXTHERAPY LIMITED (REGISTERED NUMBER: 15361511)

BALANCE SHEET
31 DECEMBER 2024

Notes £    £   
FIXED ASSETS
Tangible assets 4 2,070

CURRENT ASSETS
Cash at bank 14,702

CREDITORS
Amounts falling due within one year 5 4,344
NET CURRENT ASSETS 10,358
TOTAL ASSETS LESS CURRENT
LIABILITIES

12,428

PROVISIONS FOR LIABILITIES 6 393
NET ASSETS 12,035

CAPITAL AND RESERVES
Called up share capital 7 1
Retained earnings 12,034
SHAREHOLDERS' FUNDS 12,035

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 December 2024.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

JDXTHERAPY LIMITED (REGISTERED NUMBER: 15361511)

BALANCE SHEET - continued
31 DECEMBER 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 14 April 2025 and were signed by:





J Dhillon - Director


JDXTHERAPY LIMITED (REGISTERED NUMBER: 15361511)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD 19 DECEMBER 2023 TO 31 DECEMBER 2024

1. STATUTORY INFORMATION

Jdxtherapy Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 25% on reducing balance
Fixtures and fittings - 25% on reducing balance

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 1 .

JDXTHERAPY LIMITED (REGISTERED NUMBER: 15361511)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 19 DECEMBER 2023 TO 31 DECEMBER 2024

4. TANGIBLE FIXED ASSETS
Fixtures
Plant and and
machinery fittings Totals
£    £    £   
COST
Additions 1,334 1,427 2,761
At 31 December 2024 1,334 1,427 2,761
DEPRECIATION
Charge for period 334 357 691
At 31 December 2024 334 357 691
NET BOOK VALUE
At 31 December 2024 1,000 1,070 2,070

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
£   
Trade creditors 1,020
Tax 2,538
Directors' current accounts 786
4,344

6. PROVISIONS FOR LIABILITIES
£   
Deferred tax 393

Deferred
tax
£   
Charge to Statement of Income and Retained Earnings during period 393
Balance at 31 December 2024 393

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal
value: £   
1 Ordinary £1 1

1 Ordinary share of £1 was allotted and fully paid for cash at par during the period.